Company Showcase Information

BioTrinity provides a great platform for “Next Wave” and later stage companies to introduce their company to our audience of senior industry executives and investors via our 8 or 15 minute showcase slots.

Why showcase?
Showcasing is the ideal opportunity to directly outline research advancements to date, present strategic objectives and also highlight investment, licensing or partnership goals. Showcasing at BioTrinity will help raise your company's profile and get you in front of the key players in the life sciences field.

Presenting companies may apply or may be invited to present by BioTrinity organisers or by our Investor Sponsors.

As always the premier biotechnology conference in Europe for investors to attend. An excellent range of companies and investors present.
Carlos Pittol, Director, Clubb Capital Ltd

BioTrinity 2017 Showcase Tracks

For early stage companies, you can choose to present in:

  • Therapeutics - including 'Advanced Therapies' such as gene and cellular therapies
  • Platform Technologies
  • Medtech - including Diagnostics/Biomarkers/Medical Devices/Platform Technologies

For later stage companies (open to companies with assets that are Phase IIB ready or later, plus medical technology companies with CE marked products:

  • Pharma
  • Biotech
  • Medtech

What will you get as a showcase company?

  • Extensive profile raising opportunities ensuring visibility to hundreds of life science companies, potential partners and investors via numberous marketing emails, the website showcase page, various other pre-conference marketing materials as well as the conference handbook provided on site to all delegates
  • Access to the exclusive VIP Investor and CEO Lunch
  • Option to apply to enter the Perfect Pitch Competition
  • Access to all delegates through the industry gold-standard partneringONE system, enabling targeted 1-2-1 meeting opportunities
  • Access to keynotes and expert panel sessions, workshops and other showcase presentations
  • Access to all formal conference socials as well as informal networking during refreshment and lunch breaks
  • Company profile included in “BioTrinity 2017 Presents Europe's Most Promising Emerging Companies" booklet provided in advance to all registered investors
  • Social media re-amplification of your presentation announcement via @BioTrinity


The prices shown are in addition to the delegate registration fee that can be found here:

  Early Stage Companies (8 minute slot) Later Stage Companies (15 minute slot)
OBN Member £300 + VAT £500 + VAT
Non Member £500 + VAT £750 + VAT


Contact us

If you are interested in showcasing please contact us to discuss which Showcase Track you would like to run in and also whether you are best suited for the Early or Later Stage sessions:

Jonathan Rohll, Analyst & EU Project Manager.   Email: or tel: +44 (0)1235 420 877